Global Coronavirus (COVID-19) Current Therapy Market Overview And Top Key Players by 2030

1
Coronavirus (COVID-19) Current Therapy Market
Global Report 2020 COVID 19 Growth And Change
2
Coronavirus (COVID-19) Current Therapy
Market Characteristics

• The global COVID-19 current therapy market is
  expected to grow from 10.83 billion in 2019 to
  16.51 billion in 2020 at a compound annual
  growth rate (CAGR) of 52.5. The growth is mainly
  attributed to the COVID-19 outbreak and the
  urgent need to treat the growing number of cases.
  With no effective therapeutics discovered so far,
  existing drugs such as Remdesivir,
  Hydroxychloroquine, Ritonavir, Lopinavir,
  Interferon Beta, among others are repurposed for
  the COVID-19 treatment. The market is then
  expected to stabilize and reach 27.27 billion in
  2023 at a CAGR of 18.2.
• The Business Research Company published its
  Coronavirus (COVID-19) Current Therapy Global
  Market Report 2020 which provides strategists,
  marketers and senior management with the critical
  information they need to assess the global
  COVID-19 current therapy market. The report
  covers the coronavirus (COVID-19) current therapy
  markets segments- by drug type into antiviral
  (remdesivir, ritonavir, lopinavir), antimalarial
  (hydroxychloroquine), interferons (interferon
  beta), corticosteroid (dexamethasone), others,
  and by end-use into hospitals, clinics, research
  institutes, others.
• The major regions included in the report are
  Asia-Pacific, Western Europe, Eastern Europe,
  North America, South America, Middle East, and
  Africa.

Click Here To View Complete Report
3
Major Key PlayersModerna Therapeutics,
Novavax, Bravovax, Ascletis Pharma, Altimmune,
Clover Biopharmaceuticals, Inovio
Pharmaceuticals, Inc., Biocryst Pharma, Gilead
Sciences, Regeneron Pharmaceuticals, Applied DNA
Sciences, Inc, Codagenix, GeoVax Labs, Inc.,
Takis Biotech, Evvivax, Zydus Cadila, MIGAL
Galilee Research Institute, Generex Biotechnology
Corporation, Janssen Pharmaceuticals, Greffex
Inc., CanSino Biologics, Inc., ExpreS2ion
Biotechnologies ApS, Vaxil Bio Ltd., iBio Pharma
Inc, Tonix Pharmaceuticals, Curevac,
ImmunoPrecise, AbbVie, AbCellera / Eli Lilly,
Stemirna Therapeutics.
Click Here To Get A Sample Report
4
Table Of Content

• 1. Executive Summary
• 2. Coronavirus (COVID-19) Current Therapy Market
  Characteristics
• 3. Coronavirus (COVID-19) Current Therapy Market
  Size And Growth
• 4. Coronavirus (COVID-19) Current Therapy Market
  Segmentation
• 5. Coronavirus (COVID-19) Current Therapy Market
  Regional And Country Analysis
• ...
• 26. Key Mergers And Acquisitions In The
  Coronavirus (COVID-19) Current Therapy Market
• 27. Coronavirus (COVID-19) Current Therapy Market
  Trends And Strategies
• 28. Coronavirus (COVID-19) Current Therapy Market
  Future Outlook and Potential Analysis
• 29. Appendix
• Click Here To Get A Sample Report

5
Get In Touch
Whatever your need be, at The Business Research
Company we provide research consulting solutions
for businesses, government agencies
consultancies, and market research companies.
6
Europe The Business Research Company 47
Anchorage Point, 42 Cuba Street, Canary Wharf,
London, England, E14 8NE. 44 207 1930
708 Email info_at_tbrc.info www.tbrc.info
Asia The Business Research Company, Horizon
Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara
Hills Hyderabad (India) 500033 91
8897263534 Email info_at_tbrc.info www.tbrc.info
Americas The Business Research Company 625 South
Avenue, Apt B204, Secane, Philadelphia, PA 19018,
USA 1 3156230293 Email info_at_tbrc.info www.tbrc.
info